Antiprotozoal Activity of 1-Phenethyl-4-Aminopiperidine Derivatives
- 1 September 2009
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 53 (9) , 3815-3821
Abstract
A series of 44 4-aminopiperidine derivatives was screened in vitro against four protozoan parasites ( Trypanosoma brucei rhodesiense , Trypanosoma cruzi , Leishmania donovani , and Plasmodium falciparum ). This screening identified 29 molecules selectively active against bloodstream-form T. b. rhodesiense trypomastigotes, with 50% inhibitory concentrations (IC 50 ) ranging from 0.12 to 10 μM, and 33 compounds active against the chloroquine- and pyrimethamine-resistant K1 strain of P. falciparum (IC 50 range, 0.17 to 5 μM). In addition, seven compounds displayed activity against intracellular T. cruzi amastigotes in the same range as the reference drug benznidazole (IC 50 , 1.97 μM) but were also cytotoxic to L-6 cells, showing little selectivity for T. cruzi . None of the molecules tested showed interesting antileishmanial activity against axenic amastigotes of L. donovani . To our knowledge, this is the first report of the antitrypanosomal activity of molecules bearing the 4-aminopiperidine skeleton.Keywords
This publication has 41 references indexed in Scilit:
- New Bis(2-aminoimidazoline) and Bisguanidine DNA Minor Groove Binders with Potent in Vivo Antitrypanosomal and Antiplasmodial ActivityJournal of Medicinal Chemistry, 2008
- Targeting the polyamine biosynthetic enzymes: a promising approach to therapy of African sleeping sickness, Chagas’ disease, and leishmaniasisAmino Acids, 2007
- High-throughput screening affords novel and selective trypanothione reductase inhibitors with anti-trypanosomal activityBioorganic & Medicinal Chemistry Letters, 2007
- Antimalarial drugs inhibiting hemozoin (β-hematin) formation: A mechanistic updateLife Sciences, 2007
- Drug discovery and development for neglected parasitic diseasesNature Chemical Biology, 2006
- Innovative lead discovery strategies for tropical diseasesNature Reviews Drug Discovery, 2006
- Bisguanidine, Bis(2-aminoimidazoline), and Polyamine Derivatives as Potent and Selective Chemotherapeutic Agents against Trypanosoma brucei rhodesiense. Synthesis and in Vitro EvaluationJournal of Medicinal Chemistry, 2004
- Potent Inhibitors of Plasmodium Phospholipid Metabolism with a Broad Spectrum of In Vitro Antimalarial ActivitiesAntimicrobial Agents and Chemotherapy, 2003
- Susceptibility of Plasmodium falciparum to five drugs: an in vitro study of isolates mainly from ThailandTransactions of the Royal Society of Tropical Medicine and Hygiene, 1983
- New Culture Medium for Maintenance of Tsetse Tissues and Growth of Trypanosomatids*The Journal of Protozoology, 1977